The global market for PEG-G-CSF Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

PEG-G-CSF injection (pegfilgrastim injection) is a long-acting preparation. PEG-G-CSF injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). PEG-G-CSF injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. PEG-G-CSF is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.

North American market for PEG-G-CSF Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for PEG-G-CSF Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of PEG-G-CSF Injection include Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PEG-G-CSF Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEG-G-CSF Injection.

The PEG-G-CSF Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PEG-G-CSF Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PEG-G-CSF Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PEG-G-CSF Injection Market Report

Report Metric	Details
Report Name	PEG-G-CSF Injection Market
Segment by Type	Vial Prefilled Syringe
Segment by Application	Neoplastic Diseases Blood Disorders Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEG-G-CSF Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEG-G-CSF Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PEG-G-CSF Injection Market report?

Ans: The main players in the PEG-G-CSF Injection Market are Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, CSPC, Jiangsu Hengrui Medicine, Qilu Pharmaceutical

What are the Application segmentation covered in the PEG-G-CSF Injection Market report?

Ans: The Applications covered in the PEG-G-CSF Injection Market report are Neoplastic Diseases, Blood Disorders, Others

What are the Type segmentation covered in the PEG-G-CSF Injection Market report?

Ans: The Types covered in the PEG-G-CSF Injection Market report are Vial, Prefilled Syringe

1 PEG-G-CSF Injection Market Overview

1.1 Product Definition

1.2 PEG-G-CSF Injection by Type

1.2.1 Global PEG-G-CSF Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 Vial

1.2.3 Prefilled Syringe

1.3 PEG-G-CSF Injection by Application

1.3.1 Global PEG-G-CSF Injection Market Value by Application (2024 VS 2031)

1.3.2 Neoplastic Diseases

1.3.3 Blood Disorders

1.3.4 Others

1.4 Global PEG-G-CSF Injection Market Size Estimates and Forecasts

1.4.1 Global PEG-G-CSF Injection Revenue 2020-2031

1.4.2 Global PEG-G-CSF Injection Sales 2020-2031

1.4.3 Global PEG-G-CSF Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 PEG-G-CSF Injection Market Competition by Manufacturers

2.1 Global PEG-G-CSF Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global PEG-G-CSF Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global PEG-G-CSF Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of PEG-G-CSF Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of PEG-G-CSF Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of PEG-G-CSF Injection, Product Type & Application

2.7 Global Key Manufacturers of PEG-G-CSF Injection, Date of Enter into This Industry

2.8 Global PEG-G-CSF Injection Market Competitive Situation and Trends

2.8.1 Global PEG-G-CSF Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest PEG-G-CSF Injection Players Market Share by Revenue

2.8.3 Global PEG-G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PEG-G-CSF Injection Market Scenario by Region

3.1 Global PEG-G-CSF Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global PEG-G-CSF Injection Sales by Region: 2020-2031

3.2.1 Global PEG-G-CSF Injection Sales by Region: 2020-2025

3.2.2 Global PEG-G-CSF Injection Sales by Region: 2026-2031

3.3 Global PEG-G-CSF Injection Revenue by Region: 2020-2031

3.3.1 Global PEG-G-CSF Injection Revenue by Region: 2020-2025

3.3.2 Global PEG-G-CSF Injection Revenue by Region: 2026-2031

3.4 North America PEG-G-CSF Injection Market Facts & Figures by Country

3.4.1 North America PEG-G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America PEG-G-CSF Injection Sales by Country (2020-2031)

3.4.3 North America PEG-G-CSF Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe PEG-G-CSF Injection Market Facts & Figures by Country

3.5.1 Europe PEG-G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe PEG-G-CSF Injection Sales by Country (2020-2031)

3.5.3 Europe PEG-G-CSF Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PEG-G-CSF Injection Market Facts & Figures by Region

3.6.1 Asia Pacific PEG-G-CSF Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific PEG-G-CSF Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific PEG-G-CSF Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America PEG-G-CSF Injection Market Facts & Figures by Country

3.7.1 Latin America PEG-G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America PEG-G-CSF Injection Sales by Country (2020-2031)

3.7.3 Latin America PEG-G-CSF Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PEG-G-CSF Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa PEG-G-CSF Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa PEG-G-CSF Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa PEG-G-CSF Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global PEG-G-CSF Injection Sales by Type (2020-2031)

4.1.1 Global PEG-G-CSF Injection Sales by Type (2020-2025)

4.1.2 Global PEG-G-CSF Injection Sales by Type (2026-2031)

4.1.3 Global PEG-G-CSF Injection Sales Market Share by Type (2020-2031)

4.2 Global PEG-G-CSF Injection Revenue by Type (2020-2031)

4.2.1 Global PEG-G-CSF Injection Revenue by Type (2020-2025)

4.2.2 Global PEG-G-CSF Injection Revenue by Type (2026-2031)

4.2.3 Global PEG-G-CSF Injection Revenue Market Share by Type (2020-2031)

4.3 Global PEG-G-CSF Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global PEG-G-CSF Injection Sales by Application (2020-2031)

5.1.1 Global PEG-G-CSF Injection Sales by Application (2020-2025)

5.1.2 Global PEG-G-CSF Injection Sales by Application (2026-2031)

5.1.3 Global PEG-G-CSF Injection Sales Market Share by Application (2020-2031)

5.2 Global PEG-G-CSF Injection Revenue by Application (2020-2031)

5.2.1 Global PEG-G-CSF Injection Revenue by Application (2020-2025)

5.2.2 Global PEG-G-CSF Injection Revenue by Application (2026-2031)

5.2.3 Global PEG-G-CSF Injection Revenue Market Share by Application (2020-2031)

5.3 Global PEG-G-CSF Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amgen Inc.

6.1.1 Amgen Inc. Company Information

6.1.2 Amgen Inc. Description and Business Overview

6.1.3 Amgen Inc. PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amgen Inc. PEG-G-CSF Injection Product Portfolio

6.1.5 Amgen Inc. Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer PEG-G-CSF Injection Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Sandoz (Novartis)

6.3.1 Sandoz (Novartis) Company Information

6.3.2 Sandoz (Novartis) Description and Business Overview

6.3.3 Sandoz (Novartis) PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sandoz (Novartis) PEG-G-CSF Injection Product Portfolio

6.3.5 Sandoz (Novartis) Recent Developments/Updates

6.4 Spectrum Pharmaceuticals

6.4.1 Spectrum Pharmaceuticals Company Information

6.4.2 Spectrum Pharmaceuticals Description and Business Overview

6.4.3 Spectrum Pharmaceuticals PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Spectrum Pharmaceuticals PEG-G-CSF Injection Product Portfolio

6.4.5 Spectrum Pharmaceuticals Recent Developments/Updates

6.5 Biocon Biologics Inc.

6.5.1 Biocon Biologics Inc. Company Information

6.5.2 Biocon Biologics Inc. Description and Business Overview

6.5.3 Biocon Biologics Inc. PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Biocon Biologics Inc. PEG-G-CSF Injection Product Portfolio

6.5.5 Biocon Biologics Inc. Recent Developments/Updates

6.6 Coherus BioSciences, Inc.

6.6.1 Coherus BioSciences, Inc. Company Information

6.6.2 Coherus BioSciences, Inc. Description and Business Overview

6.6.3 Coherus BioSciences, Inc. PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Coherus BioSciences, Inc. PEG-G-CSF Injection Product Portfolio

6.6.5 Coherus BioSciences, Inc. Recent Developments/Updates

6.7 Teva Pharmaceutical

6.7.1 Teva Pharmaceutical Company Information

6.7.2 Teva Pharmaceutical Description and Business Overview

6.7.3 Teva Pharmaceutical PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Teva Pharmaceutical PEG-G-CSF Injection Product Portfolio

6.7.5 Teva Pharmaceutical Recent Developments/Updates

6.8 CSPC

6.8.1 CSPC Company Information

6.8.2 CSPC Description and Business Overview

6.8.3 CSPC PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 CSPC PEG-G-CSF Injection Product Portfolio

6.8.5 CSPC Recent Developments/Updates

6.9 Jiangsu Hengrui Medicine

6.9.1 Jiangsu Hengrui Medicine Company Information

6.9.2 Jiangsu Hengrui Medicine Description and Business Overview

6.9.3 Jiangsu Hengrui Medicine PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Jiangsu Hengrui Medicine PEG-G-CSF Injection Product Portfolio

6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates

6.10 Qilu Pharmaceutical

6.10.1 Qilu Pharmaceutical Company Information

6.10.2 Qilu Pharmaceutical Description and Business Overview

6.10.3 Qilu Pharmaceutical PEG-G-CSF Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Qilu Pharmaceutical PEG-G-CSF Injection Product Portfolio

6.10.5 Qilu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PEG-G-CSF Injection Industry Chain Analysis

7.2 PEG-G-CSF Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PEG-G-CSF Injection Production Mode & Process Analysis

7.4 PEG-G-CSF Injection Sales and Marketing

7.4.1 PEG-G-CSF Injection Sales Channels

7.4.2 PEG-G-CSF Injection Distributors

7.5 PEG-G-CSF Injection Customer Analysis

8 PEG-G-CSF Injection Market Dynamics

8.1 PEG-G-CSF Injection Industry Trends

8.2 PEG-G-CSF Injection Market Drivers

8.3 PEG-G-CSF Injection Market Challenges

8.4 PEG-G-CSF Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Amgen Inc

Sandoz(Novartis)

Spectrum Pharmaceuticals

Biocon Biologics Inc

Coherus BioSciences Inc

Teva Pharmaceutical

CSPC

Jiangsu Hengrui Medicine

Qilu Pharmaceutical

List of Tables

Table 1. Global PEG-G-CSF Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global PEG-G-CSF Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global PEG-G-CSF Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global PEG-G-CSF Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global PEG-G-CSF Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global PEG-G-CSF Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global PEG-G-CSF Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market PEG-G-CSF Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of PEG-G-CSF Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of PEG-G-CSF Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of PEG-G-CSF Injection, Product Type & Application

Table 12. Global Key Manufacturers of PEG-G-CSF Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global PEG-G-CSF Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-G-CSF Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global PEG-G-CSF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global PEG-G-CSF Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global PEG-G-CSF Injection Sales Market Share by Region (2020-2025)

Table 19. Global PEG-G-CSF Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global PEG-G-CSF Injection Sales Market Share by Region (2026-2031)

Table 21. Global PEG-G-CSF Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global PEG-G-CSF Injection Revenue Market Share by Region (2020-2025)

Table 23. Global PEG-G-CSF Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global PEG-G-CSF Injection Revenue Market Share by Region (2026-2031)

Table 25. North America PEG-G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America PEG-G-CSF Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America PEG-G-CSF Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America PEG-G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America PEG-G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe PEG-G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe PEG-G-CSF Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe PEG-G-CSF Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe PEG-G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe PEG-G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific PEG-G-CSF Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific PEG-G-CSF Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific PEG-G-CSF Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific PEG-G-CSF Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific PEG-G-CSF Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America PEG-G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America PEG-G-CSF Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America PEG-G-CSF Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America PEG-G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America PEG-G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa PEG-G-CSF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa PEG-G-CSF Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa PEG-G-CSF Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa PEG-G-CSF Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa PEG-G-CSF Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global PEG-G-CSF Injection Sales (K Units) by Type (2020-2025)

Table 51. Global PEG-G-CSF Injection Sales (K Units) by Type (2026-2031)

Table 52. Global PEG-G-CSF Injection Sales Market Share by Type (2020-2025)

Table 53. Global PEG-G-CSF Injection Sales Market Share by Type (2026-2031)

Table 54. Global PEG-G-CSF Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global PEG-G-CSF Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global PEG-G-CSF Injection Revenue Market Share by Type (2020-2025)

Table 57. Global PEG-G-CSF Injection Revenue Market Share by Type (2026-2031)

Table 58. Global PEG-G-CSF Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global PEG-G-CSF Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global PEG-G-CSF Injection Sales (K Units) by Application (2020-2025)

Table 61. Global PEG-G-CSF Injection Sales (K Units) by Application (2026-2031)

Table 62. Global PEG-G-CSF Injection Sales Market Share by Application (2020-2025)

Table 63. Global PEG-G-CSF Injection Sales Market Share by Application (2026-2031)

Table 64. Global PEG-G-CSF Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global PEG-G-CSF Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global PEG-G-CSF Injection Revenue Market Share by Application (2020-2025)

Table 67. Global PEG-G-CSF Injection Revenue Market Share by Application (2026-2031)

Table 68. Global PEG-G-CSF Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global PEG-G-CSF Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Amgen Inc. Company Information

Table 71. Amgen Inc. Description and Business Overview

Table 72. Amgen Inc. PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Amgen Inc. PEG-G-CSF Injection Product

Table 74. Amgen Inc. Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer PEG-G-CSF Injection Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Sandoz (Novartis) Company Information

Table 81. Sandoz (Novartis) Description and Business Overview

Table 82. Sandoz (Novartis) PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sandoz (Novartis) PEG-G-CSF Injection Product

Table 84. Sandoz (Novartis) Recent Developments/Updates

Table 85. Spectrum Pharmaceuticals Company Information

Table 86. Spectrum Pharmaceuticals Description and Business Overview

Table 87. Spectrum Pharmaceuticals PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Spectrum Pharmaceuticals PEG-G-CSF Injection Product

Table 89. Spectrum Pharmaceuticals Recent Developments/Updates

Table 90. Biocon Biologics Inc. Company Information

Table 91. Biocon Biologics Inc. Description and Business Overview

Table 92. Biocon Biologics Inc. PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Biocon Biologics Inc. PEG-G-CSF Injection Product

Table 94. Biocon Biologics Inc. Recent Developments/Updates

Table 95. Coherus BioSciences, Inc. Company Information

Table 96. Coherus BioSciences, Inc. Description and Business Overview

Table 97. Coherus BioSciences, Inc. PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Coherus BioSciences, Inc. PEG-G-CSF Injection Product

Table 99. Coherus BioSciences, Inc. Recent Developments/Updates

Table 100. Teva Pharmaceutical Company Information

Table 101. Teva Pharmaceutical Description and Business Overview

Table 102. Teva Pharmaceutical PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Teva Pharmaceutical PEG-G-CSF Injection Product

Table 104. Teva Pharmaceutical Recent Developments/Updates

Table 105. CSPC Company Information

Table 106. CSPC Description and Business Overview

Table 107. CSPC PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. CSPC PEG-G-CSF Injection Product

Table 109. CSPC Recent Developments/Updates

Table 110. Jiangsu Hengrui Medicine Company Information

Table 111. Jiangsu Hengrui Medicine Description and Business Overview

Table 112. Jiangsu Hengrui Medicine PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Jiangsu Hengrui Medicine PEG-G-CSF Injection Product

Table 114. Jiangsu Hengrui Medicine Recent Developments/Updates

Table 115. Qilu Pharmaceutical Company Information

Table 116. Qilu Pharmaceutical Description and Business Overview

Table 117. Qilu Pharmaceutical PEG-G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Qilu Pharmaceutical PEG-G-CSF Injection Product

Table 119. Qilu Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. PEG-G-CSF Injection Distributors List

Table 123. PEG-G-CSF Injection Customers List

Table 124. PEG-G-CSF Injection Market Trends

Table 125. PEG-G-CSF Injection Market Drivers

Table 126. PEG-G-CSF Injection Market Challenges

Table 127. PEG-G-CSF Injection Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of PEG-G-CSF Injection

Figure 2. Global PEG-G-CSF Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PEG-G-CSF Injection Market Share by Type: 2024 & 2031

Figure 4. Vial Product Picture

Figure 5. Prefilled Syringe Product Picture

Figure 6. Global PEG-G-CSF Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global PEG-G-CSF Injection Market Share by Application: 2024 & 2031

Figure 8. Neoplastic Diseases

Figure 9. Blood Disorders

Figure 10. Others

Figure 11. Global PEG-G-CSF Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global PEG-G-CSF Injection Market Size (2020-2031) & (US$ Million)

Figure 13. Global PEG-G-CSF Injection Sales (2020-2031) & (K Units)

Figure 14. Global PEG-G-CSF Injection Average Price (US$/Unit) & (2020-2031)

Figure 15. PEG-G-CSF Injection Report Years Considered

Figure 16. PEG-G-CSF Injection Sales Share by Manufacturers in 2024

Figure 17. Global PEG-G-CSF Injection Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest PEG-G-CSF Injection Players: Market Share by Revenue in PEG-G-CSF Injection in 2024

Figure 19. PEG-G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global PEG-G-CSF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America PEG-G-CSF Injection Sales Market Share by Country (2020-2031)

Figure 22. North America PEG-G-CSF Injection Revenue Market Share by Country (2020-2031)

Figure 23. United States PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe PEG-G-CSF Injection Sales Market Share by Country (2020-2031)

Figure 26. Europe PEG-G-CSF Injection Revenue Market Share by Country (2020-2031)

Figure 27. Germany PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific PEG-G-CSF Injection Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific PEG-G-CSF Injection Revenue Market Share by Region (2020-2031)

Figure 34. China PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America PEG-G-CSF Injection Sales Market Share by Country (2020-2031)

Figure 42. Latin America PEG-G-CSF Injection Revenue Market Share by Country (2020-2031)

Figure 43. Mexico PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa PEG-G-CSF Injection Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa PEG-G-CSF Injection Revenue Market Share by Country (2020-2031)

Figure 48. Turkey PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE PEG-G-CSF Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of PEG-G-CSF Injection by Type (2020-2031)

Figure 52. Global Revenue Market Share of PEG-G-CSF Injection by Type (2020-2031)

Figure 53. Global PEG-G-CSF Injection Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of PEG-G-CSF Injection by Application (2020-2031)

Figure 55. Global Revenue Market Share of PEG-G-CSF Injection by Application (2020-2031)

Figure 56. Global PEG-G-CSF Injection Price (US$/Unit) by Application (2020-2031)

Figure 57. PEG-G-CSF Injection Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global PEG-G-CSF Injection Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-32L16141

Global PEG-G-CSF Injection Market Research Report 2025

FEATURED COMPANIES

PEG-G-CSF Injection Market

Report Scope

Scope of PEG-G-CSF Injection Market Report

Core Chapters

FAQ for this report

Who are the main players in the PEG-G-CSF Injection Market report?

What are the Application segmentation covered in the PEG-G-CSF Injection Market report?

What are the Type segmentation covered in the PEG-G-CSF Injection Market report?

FEATURED COMPANIES

RELATED REPORTS

Single User, Electronic (PDF)

Global Smart Transportation Market Size Status and Forecast 2020 2026

Single User,

heavy construction equipment market

Single User, Electronic (PDF)